Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer

NCT02595138 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

430

Enrollment

OTHER

Sponsor class

Conditions

Triple Negative Breast Cancer

Interventions

DRUG: Zoledronic acid

Sponsor

Chinese Academy of Medical Sciences

Collaborators

[object Object]